PURPOSE: We surveyed how radiation oncologists think about and incorporate a palliative cancer patient's life expectancy (LE) into their treatment recommendations. METHODS AND MATERIALS: A 41-item survey was e-mailed to 113 radiation oncology attending physicians and residents at radiation oncology centers within the Boston area. Physicians estimated how frequently they assessed the LE of their palliative cancer patients and rated the importance of 18 factors in formulating LE estimates. For 3 common palliative case scenarios, physicians estimated LE and reported whether they had an LE threshold below which they would modify their treatment recommendation. LE estimates were considered accurate when within the 95% confidence interval of median survival estimates from an established prognostic model. RESULTS: Among 92 respondents (81%), the majority were male (62%), from an academic practice (75%), and an attending physician (70%). Physicians reported assessing LE in 91% of their evaluations and most frequently rated performance status (92%), overall metastatic burden (90%), presence of central nervous system metastases (75%), and primary cancer site (73%) as "very important" in assessing LE. Across the 3 cases, most (88%-97%) had LE thresholds that would alter treatment recommendations. Overall, physicians' LE estimates were 22% accurate with 67% over the range predicted by the prognostic model. CONCLUSIONS: Physicians often incorporate LE estimates into palliative cancer care and identify important prognostic factors. Most have LE thresholds that guide their treatment recommendations. However, physicians overestimated patient survival times in most cases. Future studies focused on improving LE assessment are needed.
PURPOSE: We surveyed how radiation oncologists think about and incorporate a palliative cancerpatient's life expectancy (LE) into their treatment recommendations. METHODS AND MATERIALS: A 41-item survey was e-mailed to 113 radiation oncology attending physicians and residents at radiation oncology centers within the Boston area. Physicians estimated how frequently they assessed the LE of their palliative cancerpatients and rated the importance of 18 factors in formulating LE estimates. For 3 common palliative case scenarios, physicians estimated LE and reported whether they had an LE threshold below which they would modify their treatment recommendation. LE estimates were considered accurate when within the 95% confidence interval of median survival estimates from an established prognostic model. RESULTS: Among 92 respondents (81%), the majority were male (62%), from an academic practice (75%), and an attending physician (70%). Physicians reported assessing LE in 91% of their evaluations and most frequently rated performance status (92%), overall metastatic burden (90%), presence of central nervous system metastases (75%), and primary cancer site (73%) as "very important" in assessing LE. Across the 3 cases, most (88%-97%) had LE thresholds that would alter treatment recommendations. Overall, physicians' LE estimates were 22% accurate with 67% over the range predicted by the prognostic model. CONCLUSIONS: Physicians often incorporate LE estimates into palliative cancer care and identify important prognostic factors. Most have LE thresholds that guide their treatment recommendations. However, physicians overestimated patient survival times in most cases. Future studies focused on improving LE assessment are needed.
Authors: Jennifer S Temel; Joseph A Greer; Alona Muzikansky; Emily R Gallagher; Sonal Admane; Vicki A Jackson; Constance M Dahlin; Craig D Blinderman; Juliet Jacobsen; William F Pirl; J Andrew Billings; Thomas J Lynch Journal: N Engl J Med Date: 2010-08-19 Impact factor: 91.245
Authors: William F Hartsell; Charles B Scott; Deborah Watkins Bruner; Charles W Scarantino; Robert A Ivker; Mack Roach; John H Suh; William F Demas; Benjamin Movsas; Ivy A Petersen; Andre A Konski; Charles S Cleeland; Nora A Janjan; Michelle DeSilvio Journal: J Natl Cancer Inst Date: 2005-06-01 Impact factor: 13.506
Authors: Edward Chow; Lori Davis; Tony Panzarella; Charles Hayter; Ewa Szumacher; Andrew Loblaw; Rebecca Wong; Cyril Danjoux Journal: Int J Radiat Oncol Biol Phys Date: 2005-03-01 Impact factor: 7.038
Authors: Nancy L Keating; Mary Beth Landrum; Selwyn O Rogers; Susan K Baum; Beth A Virnig; Haiden A Huskamp; Craig C Earle; Katherine L Kahn Journal: Cancer Date: 2010-02-15 Impact factor: 6.860
Authors: Alysa Fairchild; Elizabeth Barnes; Sunita Ghosh; Edgar Ben-Josef; Daniel Roos; William Hartsell; Tanya Holt; Jackson Wu; Nora Janjan; Edward Chow Journal: Int J Radiat Oncol Biol Phys Date: 2009-05-21 Impact factor: 7.038
Authors: Haiden A Huskamp; Nancy L Keating; Jennifer L Malin; Alan M Zaslavsky; Jane C Weeks; Craig C Earle; Joan M Teno; Beth A Virnig; Katherine L Kahn; Yulei He; John Z Ayanian Journal: Arch Intern Med Date: 2009-05-25
Authors: Sara Mandelli; Emma Riva; Mauro Tettamanti; Ugo Lucca; Davide Lombardi; Gianmaria Miolo; Simon Spazzapan; Rita Marson Journal: Support Care Cancer Date: 2020-08-31 Impact factor: 3.603
Authors: Yolanda D Tseng; Monica S Krishnan; Joshua A Jones; Adam J Sullivan; Daniel Gorman; Allison Taylor; Michael Pacold; Barbara Kalinowski; Harvey J Mamon; Janet Abrahm; Tracy A Balboni Journal: Pract Radiat Oncol Date: 2013-11-20
Authors: Sara R Alcorn; Jacob Fiksel; Jean L Wright; Christen R Elledge; Thomas J Smith; Powell Perng; Sarah Saleemi; Todd R McNutt; Theodore L DeWeese; Scott Zeger Journal: Int J Radiat Oncol Biol Phys Date: 2020-05-22 Impact factor: 7.038
Authors: Katie Spencer; Eva Morris; Emma Dugdale; Alexander Newsham; David Sebag-Montefiore; Rob Turner; Geoff Hall; Adrian Crellin Journal: Radiother Oncol Date: 2015-04-07 Impact factor: 6.280
Authors: Sebastian M Christ; Markus Schettle; Annina Seiler; Matthias Guckenberger; David Blum; Nicolaus Andratschke; Caroline Hertler Journal: Clin Transl Radiat Oncol Date: 2021-07-04